A federal judge in Ohio who oversees the National Prescription Opiate Litigation (NPOL) has recently issued a ruling with significant implications for pharmacists and pharmacies.

David B. Brushwood, BSPharm, JD

Mental health disorders are common, complex to diagnose and treat, and costly to manage. They are also associated with a high risk of morbidity and mortality. Common disorders such as depression and anxiety are among the leading causes of disease burden globally. WHO reports that anxiety disorders affect over 260 million people.

Adrijana Kekic, PharmD, CTLC

Topical analgesics are often used to relieve pain associated with aches and pains in muscles and joints, such as backaches, arthritis, strains, bruises, and sprains.

Mary Warner

The American Society of Health-System Pharmacists (ASHP) and ASHP Foundation released the 11th edition of the Pharmacy Forecast report, which provides an insightful perspective on the factors that can affect patient care, population health, and the pharmacy profession.

Aneesh Asokan, PharmD, MBA

An article published on January 21, 2023, in AJHP reveals some welcome findings: When pharmacists are involved in antibiotic selection, hospitals can potentially save money and patients are less likely to be prescribed undesirable second-line therapies.

Olivia C. Welter, PharmD

A Minute With... 

Samantha Freiter, APhA–ASP Chapter President
and 2024 PharmD candidate, University of Pittsburgh
School of Pharmacy

Member since 2020

FDA issued an EUA on February 24, 2023, for the first at-home OTC diagnostic test that can differentiate and detect influenza A and B and the SARS-CoV-2 virus.

As an age-advanced (i.e., older) pharmacist, I can remember the days when proton-pump inhibitors, H2 receptor antagonists, fluticasone nasal spray, and many other self-care products required a prescription.

Kristin Wiisanen, PharmD, FAPhA, FCCP

The momentum is building for PBM reform and APhA remains focused on challenging PBM’s anticompetitive business practices which create an unequal playing field in the marketplace that disadvantages patients, pharmacists, and communities.

Ilisa BG Bernstein, PharmD, JD, FAPhA

Take the Crossword Challenge